Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), together with the American Association of Bioanalysts, American Society for Clinical Pathology, American Society for Microbiology, and the Infectious Disease Society of America, has filed an amicus brief in the case of American Clinical Laboratory Association (ACLA), et al. v. U.S. Food and Drug Administration (FDA), et al.
Tag: ADLM
ADLM publishes new guidance on lipid testing to improve care for patients with cardiovascular disease
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) has issued expert guidance on lipid tests, which measure blood levels of fats and cholesterol to help assess a patient’s risk of heart disease and stroke. By giving clinicians and laboratory medicine professionals much-needed clarity on how to best use these tests, the new guidelines will ensure that more patients with cardiovascular disease get the treatment they need.
Video and Transcript Available – FDA Changes to Laboratory Developed Test Regulation: Livestreamed Expert Panel
Live from the annual conference of the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), experts will discuss how the new FDA rule on laboratory developed tests will hinder patient care. This rule will place these tests under duplicative FDA oversight, even though laboratory developed tests are already regulated by the Centers for Medicare & Medicaid Services. This will force many labs to stop performing these essential tests, which play a critical role in diagnosing rare disorders, such as inherited genetic conditions in newborns.
Expert insights on laboratory developed tests, the consequences of ending abortion protection, health equity, and more draw 18,000 attendees to ADLM 2024
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), welcomed thousands of laboratory experts to ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) from July 28-August 1. The meeting featured groundbreaking advances in diagnostic research and technology that exemplify the essential role that the field of laboratory medicine plays in patient care.
New research shows how machine learning could revolutionize diagnosis and treatment of multiple myeloma and sepsis
Exciting research at the frontier of artificial intelligence and data science in laboratory medicine was presented today at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo).
New test can detect patients’ risk of harmful side effects from Alzheimer’s drugs
Today at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will present data on a novel test that predicts whether Alzheimer’s patients are genetically predisposed to side effects from anti-amyloid drugs, a promising new class of Alzheimer’s therapeutics.
Novel study reveals that a surprising number of pregnant people are using cannabis — and need to be informed of its risks
Breaking research shows that rates of cannabis use during pregnancy are far higher than previously thought, a finding that could improve efforts to identify pregnant cannabis users and inform them of potential risks.
Breaking research on the use of race in prenatal screens, health outcomes of HIV-exposed children could advance healthcare for underserved populations
In a new study, researchers have demonstrated that there is an insufficient basis for incorporating race in prenatal screening for birth defects. In a second, separate study, researchers have found that HIV-exposed uninfected children are at higher risk for health problems compared to uninfected, unexposed children.
Biosynth to Unveil Groundbreaking Animal-Free Reagent and Critical Mpox Detection Tools at ADLM Show
Biosynth, a leader in life science reagents, invites you to an exclusive press conference at the ADLM show where we will unveil two major advancements with the potential to transform research and diagnostics.
ADLM announces 2024 Top Corporate Supporter Award recipients and thanks them for their vital backing
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce the recipients of its 2024 Top Corporate Supporter Award, a distinction given to companies and organizations that generously support the association through advertising, sponsorships, and exhibits.
The New MagBinder® Fit24 Nucleic Acid Purification System Introduced at the 2024 ADLM in Chicago
Omega Bio-tek announces the release of the MagBinder® Fit24, its first piece of hardware for labs isolating DNA or RNA from various sample types for downstream analysis.
World Premiere: Inpeco Launches its Next-Generation Total Lab Automation System at the ADLM 2024 in Chicago
Inpeco SA pioneered lab automation in 1995. Today, we are the global leader in total laboratory automation (TLA), with over 2,600 systems delivered worldwide.
The consequences of ending abortion protection, the patient perspective on laboratory developed tests, health equity, and more to be explored at ADLM 2024
At ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago, more than 300 experts will present cutting-edge research and technology that will shape the future of laboratory medicine and improve patient care.
Certest Biotec: “We use our human potential to improve global health and provide an immediate response”
Certest Biotec, is a Spanish an innovative and technology-based company founded in 2002 that has always relied on research and development of new products, as well as exploration of new market niches and opportunities, for its growth.
The Association for Diagnostics & Laboratory Medicine (formerly AACC) supports Rep. Cassidy’s letter asking the FDA to explain how it plans to abide by the recent Supreme Court decision curtailing the power of federal agencies
On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and reinforced that Congress and the courts are responsible for writing and interpreting laws, respectively, not federal agencies.
Association for Diagnostics & Laboratory Medicine (formerly AACC) honors Representatives John Joyce, MD, and Cathy McMorris Rodgers for their commitment to ensuring that patients have access to high quality clinical tests
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce that Representatives John Joyce, MD (R-Pa.), and Cathy McMorris Rodgers (R-Wash.) are the recipients of ADLM’s Outstanding Legislator Awards for the 118th Congress.
Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.’s drug epidemic
Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s (FDA’s) final laboratory developed tests rule will impact patient access to essential tests. The survey found that, in spite of certain tests being exempt from the rule, it will still force many laboratories, particularly those in hospitals, to discontinue critical tests, including those needed to identify prescription and illegal drug use.
MEDIA ADVISORY – Webinar: The U.S. FDA’s rule on LDTs – What it means for you
The U.S. Food and Drug Administration (FDA) has long sparked controversy with its proposals to regulate laboratory developed tests (LDTs) as medical devices.
ADLM announces 2024 award winners; celebrates achievements in laboratory medicine
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy recognize individuals around the world for outstanding research and service in the field of laboratory medicine and highlight the vital contributions made by all lab professionals to patient care.
Association for Diagnostics & Laboratory Medicine (formerly AACC) Submits Testimony to Congress Opposing FDA’s Proposed LDTs Rule
“Today, we at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) provided testimony to Congress regarding the impact of the Food and Drug Administration’s (FDA’s) proposed rule to impose FDA oversight on laboratory developed tests in addition to Centers for Medicare & Medicaid Services (CMS) oversight. While we share FDA’s goal of ensuring that laboratory developed tests are safe and effective, we have serious concerns about the agency’s proposal. If finalized, this rule would create a burdensome dual regulatory structure that would limit patient access to many life-saving tests.
Strategies Behind Near-Zero COVID-19 Incidence in NBA “Bubble” Published in ADLM’s The Journal of Applied Laboratory Medicine
A report published today in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) The Journal of Applied Laboratory Medicine describes the strategies used by the National Basketball Association (NBA) to limit COVID-19 exposure among the individuals who participated in the 2019–2020 season. The success of the NBA’s approach demonstrates that strict adherence to certain protocols can be highly effective in preventing disease outbreaks in a self-contained environment and serves as a model for future pandemic management.
Maritel Dasco Named the Chief Financial Officer of ADLM
The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce that Maritel Dasco assumed the position of chief financial officer (CFO) for the association on September 25.
Association for Diagnostics & Laboratory Medicine (formerly AACC) Statement on Proposed FDA Rule on Laboratory Developed Tests
We at the Association for Diagnostics & Laboratory Medicine were disappointed to see the U.S. Food & Drug Administration’s (FDA’s) attempt to circumvent Congress with its new proposed rule to duplicate the regulation of laboratory developed tests by placing these tests under FDA authority, in addition to their current regulation under the Centers for Medicare and Medicaid Services.